Literature DB >> 10367258

Influence of phosphotyrosine kinase inhibitors on adhesive properties of highly and poorly metastatic HT-29 colon carcinoma cells to collagen.

J Haier1, M Nasralla, G L Nicolson.   

Abstract

Organ-specific sites of metastastic lesions are determined in part by integrin-mediated adhesion to extracellular matrix (ECM) components. Using poorly (HT-29P) and highly liver-metastatic (HT-29LMM) colon carcinoma cells we previously found different integrin-mediated adhesion to various ECM components, but similar integrin expression of both cell lines. These HT-29 cell lines were used to study adhesion to collagen I (C I) and possible intracellular signaling mechanisms that could explain different adhesive properties. HT-29LMM cells had significantly poorer rates of adhesion to C I (P < 0.05) than HT-29P cells. For examination of the integrin subunits involved in adhesion to C I, cells were treated with various anti-integrin antibodies. These results demonstrated that adhesion of HT-29 cells to C I is mediated in part by the alpha 2 beta 1 integrin. Using immunoprecipitation and Western blotting, both cell lines expressed similar patterns of integrins (alpha 2, alpha 3, alpha 6, and beta 1). Weaker signals were found for the expression of alpha v and beta 5 integrins. Although poorly and highly metastatic cells possessed different patterns of adhesion to C I, these differences were not caused by different expression of integrin subunits. For investigation of the involvement of phosphotyrosine kinases in adhesion, cells were pretreated with the Erbstatin analog, Genistein, or Herbimycin A. Genistein transiently stimulated the adhesive properties of both cell lines. In contrast, Herbimycin A had biphasic effects. At lower concentrations of Herbimycin A stimulation of adhesion was found after 30 and 90 min. However, higher concentrations inhibited adhesive properties. The stimulatory effect was more pronounced in poorly metastatic HT-29P cells. The Erbstatin analog had no effect, probably because of the lack of epidermal growth factor receptor expression in both cell lines. The results suggest that adhesion of tumor cells to ECM components may be dependent on signal transduction into the cell, and tyrosine phosphorylation appears to be involved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367258     DOI: 10.1007/s003840050196

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  7 in total

1.  Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow.

Authors:  J Haier; M Y Nasralla; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 2.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Role of the cytoskeleton in adhesion stabilization of human colorectal carcinoma cells to extracellular matrix components under dynamic conditions of laminar flow.

Authors:  J Haier; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Sebastian Zuber; Jens Otto; Lothar Tietze; Volker Schumpelick
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction.

Authors:  Peter Gassmann; Mi-Li Kang; Soeren T Mees; Joerg Haier
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

6.  Phospholipids reduce gastric cancer cell adhesion to extracellular matrix in vitro.

Authors:  Marc Jansen; Karl-Heinz Treutner; Britta Schmitz; Jens Otto; Petra Lynen Jansen; S Neuss; Volker Schumpelick
Journal:  BMC Gastroenterol       Date:  2004-12-29       Impact factor: 3.067

7.  In vitro study on anti-cancer properties of genistein in tongue cancer.

Authors:  Fatima Ardito; Mario R Pellegrino; Donatella Perrone; Giuseppe Troiano; Armando Cocco; Lorenzo Lo Muzio
Journal:  Onco Targets Ther       Date:  2017-11-13       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.